Case Report
Accepted on 09 Feb 2026
Safety Analysis of Blinatumomab Consolidation Therapy in Two Cases of Acute B-Cell Lymphoblastic Leukemia in Complete Remission Complicated with Immune Effector Cell-Associated Neurotoxicity Syndrome
in Hematologic Malignancies